Join Morrison Foerster at the Food and Drug Law Institute’s (FDLI) Clinical Trials: Deconstructing Challenges and Providing Practical Insights Conference. This conference will provide valuable insight on complex issues related to clinical trial type, design, labeling; clinical trial innovations; global expansion of clinical trials; clinical trial transparency, diversity, and patient engagement, as well as practical tools to comply with increased clinical trial enforcement.
On Wednesday, November 2 from 4:15 p.m. – 5:15 p.m. EST, MoFo partner Stacy Amin will moderate the Compliance and Cybersecurity Challenges in Clinical Trial Enforcement panel, featuring Selena Evans, Senior Director, Pharmacy & Healthcare Compliance, Walgreens; Natasha V. Leskovsek, Of Counsel, Cooley LLP; Peter V. Lindsay, Partner, Paul Hastings LLP; and Clint Narver, Assistant Director, Consumer Protection Branch, DOJ. This session will address common compliance questions arising from enforcement, including greater FDA oversight of clinicaltrials.gov, interest in identifying and prosecuting clinical trial fraud and misconduct, and concerns about data integrity.
For more information or to register, please visit the FDLI website.